KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Repurchased
Ratios

Pacira BioSciences (PCRX) Leases (2019 - 2025)

Historic Leases for Pacira BioSciences (PCRX) over the last 10 years, with Q3 2025 value amounting to $44.3 million.

  • Pacira BioSciences' Leases fell 1776.7% to $44.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.3 million, marking a year-over-year decrease of 1776.7%. This contributed to the annual value of $49.2 million for FY2024, which is 1933.46% down from last year.
  • As of Q3 2025, Pacira BioSciences' Leases stood at $44.3 million, which was down 1776.7% from $46.5 million recorded in Q2 2025.
  • Over the past 5 years, Pacira BioSciences' Leases peaked at $76.4 million during Q4 2021, and registered a low of $44.3 million during Q3 2025.
  • For the 5-year period, Pacira BioSciences' Leases averaged around $62.8 million, with its median value being $65.8 million (2023).
  • In the last 5 years, Pacira BioSciences' Leases soared by 9378.41% in 2021 and then tumbled by 1933.46% in 2024.
  • Quarter analysis of 5 years shows Pacira BioSciences' Leases stood at $76.4 million in 2021, then fell by 7.24% to $70.9 million in 2022, then fell by 13.91% to $61.0 million in 2023, then fell by 19.33% to $49.2 million in 2024, then dropped by 10.07% to $44.3 million in 2025.
  • Its last three reported values are $44.3 million in Q3 2025, $46.5 million for Q2 2025, and $48.7 million during Q1 2025.